Musculoskeletal Diseases Treatment Market is expected to reach US$ 5,730.8 Mn with a CAGR of 5.3% from 2018-2025

According to The Insight Partners market research study titled ‘Musculoskeletal Diseases Treatment Market to 2025 – Global Analysis and Forecasts by Disease and Imaging Modality. The global musculoskeletal diseases treatment market is expected to reach US$ 5,730.8 Mn in 2025 from US$ 3,837.9 in 2017. The musculoskeletal diseases treatment market is estimated to grow with a CAGR of 5.3% from 2018-2025.The report highlights the trends prevalent in the global musculoskeletal diseases treatment market and the factors driving the market along with those that act as deterrents to its growth.

Request for sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPMD00002090/ 

Global musculoskeletal diseases treatment market, based on the disease into arthritis, osteoarthritis, osteoporosis, spondylitis, and others. The arthritis is the largest segment among the disease segment in the musculoskeletal diseases treatment market in 2017 and is also anticipated to hold the largest market in the year 2025 owing to the increasing prevalence of the disease and the higher acceptance of the population for the MRI for the diagnosis. However, the spondylitis segment is fastest growing segment and is accounted to grow at the highest CAGR during the forecast period.

The market for musculoskeletal diseases treatment is expected to grow due to rising prevalence of musculoskeletal disorders, increasing elderly population, and technological advancements in musculoskeletal disease diagnosis are boosting the market over the years. In addition, the development of hybrid diagnostic systems are likely to have a positive impact on the growth of the market in the coming years.

The major players operating in the musculoskeletal diseases treatment market include General Electric, Koninklijke Philips N.V., Siemens AG, Canon Medical Systems Corporation, Hitachi, Ltd., Accuray Incorporated, MR Solutions, Alltech Medical Systems, Terason Division Teratech Corporation, and Echo-Son SA. For instance, in September 2018, Royal Philips launched the Ingenia Ambition X 1.5T MR. The product is the latest advance in the Ingenia MRI portfolio, that comprises fully-digital MRI systems, healthcare informatics and a range  of maintenance and life cycle services for integrated solutions that empower a faster, smarter, and simpler path to enabling a confident diagnosis. The developments performed by the companies are helping the market to grow in the coming years.

Market Insights

Rising Prevalence of Musculoskeletal Disorders

Musculoskeletal disorders are associated with sports, occupational injuries and age-related dysfunction. Some of the most common musculoskeletal diseases are back pain, rheumatoid arthritis, osteoarthritis, osteoporosis, septic arthritis, gout, myasthenia gravis, systemic lupus erythematous (SLE), and others. Musculoskeletal system is the diagnosis and management of all acute and chronic conditions affecting musculoskeletal system, i.e., muscles, bones, tendons, joints and ligaments and treatment of non-surgical lesions of the musculoskeletal system. The rising prevalence of musculoskeletal diseases are the major factors of the market growth. For instance, according to Arthritis Foundation, in 2017, approximately 54 million adults have been diagnosed with arthritis. Almost 300,000 babies and children have arthritis or a rheumatic condition. The common type of arthritis is osteoarthritis, which affects approximately 31 million Americans. By the end of 2040, number of people expected to have doctor-diagnosed arthritis will be above 78 million. As per the report published in 2018 of Healthline Media, rheumatoid arthritis (RA) affects 41 in every 100,000 people per year. Approximately, 1.3 million Americans have RA. Women are about two to three times more likely to get RA than men. The lifetime risk of developing RA is 3.6% for women and 1.7% for men. However, RA can strike at any age even small children can get it. Smoking is the mostly associated risk factor when it comes to the onset of RA in patients. A history of smoking is said to increase the risk of developing RA by as much 2.4%.

Technological Advancements in Musculoskeletal Disease Diagnosis

Musculoskeletal diseases treatment is performed with the help of most flexible diagnostic imaging modalities that has capabilities to characterize a wide range of parameters in the living subject as well as provide an exquisite spatial resolution. This technique has been explored by the numerous market players to achieve remarkable precision through extensive innovation in the product design and features. Various recent technological developments are marked in the evolution of musculoskeletal diseases treatment techniques over the past few years.

For instance, in June 2018, Konica Minolta Healthcare Americas, Inc., launched the SONIMAGE MX1 portable ultrasound system, developed for musculoskeletal (MSK) and orthopedic practices, interventional guidance and outpatient centers. SONIMAGE MX1 is made with power, portability that physicians need to make a confident and efficient diagnosis at the point-of-care. In March 2018, Philips introduced a new 3-tesla MRI scanner named Ingenia Elition 3.0T at the ECR 2018 in Vienna. Thus, the innovative steps and technological advancements undertaken by new entrants as well as established market players to improve the quality and efficacy of musculoskeletal diseases treatment scans is expected to favor the growth of the market in the years to come.

The report segments the global musculoskeletal diseases treatment market as follows:

Global Musculoskeletal Diseases Treatment Market – By Disease

Arthritis
Osteoarthritis
Osteoporosis
Spondylitis
Others

Global Musculoskeletal Diseases Treatment Market – By Imaging Modality

Magnetic Resonance Imaging (MRI)
Computed Tomography (CT)
Ultrasound
Others

Global Musculoskeletal Diseases Treatment Market – By Geography

North America

U.S.
Canada
Mexico

Europe

U.K.
Germany
France

Asia Pacific (APAC)

Japan
China
India

Middle East & Africa (MEA)

South Africa
UAE
Saudi Arabia

South & Central America (SCAM)

Brazil

Purchase Copy of This Report at https://www.theinsightpartners.com/buy/TIPMD00002090/

Tags: Musculoskeletal Diseases Treatment Market Size, Musculoskeletal Diseases Treatment Market Share, Musculoskeletal Diseases Treatment Market Trends, Musculoskeletal Diseases Treatment Market Analysis, Musculoskeletal Diseases Treatment Market Forecast, Musculoskeletal Diseases Treatment Market Outlook, Musculoskeletal Diseases Treatment, Musculoskeletal Diseases Treatment Market Overview, Musculoskeletal Diseases Treatment Market Insights, Musculoskeletal Diseases Treatment Market Type, Musculoskeletal Diseases Treatment Market Analysis Report, Musculoskeletal Diseases Treatment Insight, Musculoskeletal Diseases Treatment Industry Analysis, Musculoskeletal Diseases Treatment Research Reports, Musculoskeletal Diseases Treatment Market,   See Campaign: https://www.theinsightpartners.com/reports/musculoskeletal-diseases-treatment-market
Contact Information:
Sameer Joshi Phone: +1-646-491-9876 Email Id: sales@theinsightpartners.com

Tags:
, Menafn, Research Newswire, English